# Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

> **NCT04906369** · — · SUSPENDED · sponsor: **Mayo Clinic** · enrollment: 150 (estimated)

## Conditions studied

- Anatomic Stage IV Breast Cancer AJCC v8
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT04906369
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-11-16
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** lack of funding
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906369, "Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04906369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*